9530 PADGETT STREET, SAN DIEGO, CA
CV Sciences, Inc. Holds 2026 Annual Meeting; Director Elections Conducted
Reports First Quarter-End 2026 Financial Results
CV Sciences, Inc. Enters into $2.2 Million Note Purchase Agreements
Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth
Reports Third Quarter 2025 Financial Results
News, Material Contracts
Earnings Release
Q1
FY 2025
Q3
Q2
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Notice of Exempt Offering of Securities
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Prospectus filed pursuant to Rule 305(b)(2)
Correspondence
Submission Upload
Confidential Treatment Order
Delisting Amendment
Registration of Securities under Section 12(g)